WHITBY GROUP PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: B82017 | WHITBY, YO21 1SD
Showing results 601-650 of 740
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 19 | 134.4K | £1.6K | -56.6% ▼ |
| Capsaicin | 19 | 1,020 | £707 | +140.7% ▲ |
| Pilocarpine hydrochloride | 19 | 230 | £593 | +85.1% ▲ |
| Clindamycin phosphate | 19 | 720 | £139 | +15.5% ▲ |
| 19 | 160 | £517 | +223.1% ▲ | |
| 19 | 1,140 | £830 | +162.6% ▲ | |
| Budesonide | 18 | 825 | £1.3K | +14.9% ▲ |
| Sodium cromoglicate | 18 | 4,300 | £6.4K | +74.0% ▲ |
| Phosphates (Rectal) | 18 | 184 | £1.2K | +47.3% ▲ |
| Aspirin | 18 | 511 | £16 | +83.2% ▲ |
| Co-proxamol (Dextropropoxyphene hydrochloride/paracetamol) | 18 | 3,400 | £11.1K | +66.3% ▲ |
| Phenytoin | 18 | 20.5K | £167 | +64.0% ▲ |
| Fosfomycin trometamol | 18 | 19 | £86 | -36.7% ▼ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 18 | 133.0K | £809 | -11.0% ▼ |
| Other sunscreening preparations | 18 | 2,375 | £174 | +129.7% ▲ |
| Benzalkonium chloride | 18 | 4,500 | £101 | +56.9% ▲ |
| Chlorhexidine gluconate | 18 | 8,250 | £136 | -39.0% ▼ |
| 18 | 2,310 | £4.7K | -46.7% ▼ | |
| 18 | 157 | £845 | -12.3% ▼ | |
| 18 | 180 | £527 | -11.9% ▼ | |
| 18 | 1,080 | £3.9K | +65.5% ▲ | |
| 18 | 540 | £428 | +173.0% ▲ | |
| Citalopram hydrochloride | 17 | 390 | £278 | +5.9% ▲ |
| Analgesics with anti-emetics | 17 | 444 | £143 | +20.1% ▲ |
| Cenobamate | 17 | 476 | £2.9K | -29.8% ▼ |
| Sodium feredetate | 17 | 7,210 | £206 | -40.6% ▼ |
| Magnesium glycerophosphate | 17 | 1,424 | £590 | +23.7% ▲ |
| Ketotifen fumarate | 17 | 540 | £119 | +82.7% ▲ |
| Acetazolamide | 17 | 1,090 | £44 | -21.5% ▼ |
| Apraclonidine | 17 | 224 | £752 | +35.0% ▲ |
| 17 | 830 | £4.0K | +38.6% ▲ | |
| 17 | 990 | £568 | +59.8% ▲ | |
| Nicotine | 16 | 378 | £544 | -71.7% ▼ |
| Riboflavin | 16 | 1,920 | £479 | +73.1% ▲ |
| Tube feed 1 kcal/ml with fibre (0914011) | 16 | 475.5K | £7.2K | +55.0% ▲ |
| Carbomer 974P | 16 | 160 | £69 | +97.6% ▲ |
| Acrivastine | 15 | 1,164 | £340 | +21.8% ▲ |
| Aripiprazole | 15 | 15 | £3.0K | -1.5% vs avg |
| Exenatide | 15 | 60 | £1.1K | -14.4% ▼ |
| Lanreotide | 15 | 15 | £8.1K | +62.6% ▲ |
| 15 | 130 | £424 | +149.7% ▲ | |
| 15 | 990 | £521 | +49.3% ▲ | |
| 15 | 820 | £570 | -63.4% ▼ | |
| 15 | 300 | £759 | -26.8% ▼ | |
| Mexiletine hydrochloride | 14 | 784 | £3.5K | +144.5% ▲ |
| Formoterol/glycopyrronium/budesonide | 14 | 14 | £592 | -76.8% ▼ |
| Cyclizine lactate | 14 | 100 | £114 | -6.7% ▼ |
| Naratriptan hydrochloride | 14 | 198 | £120 | -46.5% ▼ |
| Ivermectin | 14 | 73 | £919 | +43.5% ▲ |
| Propiverine hydrochloride | 14 | 784 | £1.0K | -6.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.